Table 2.
Clinicopathological characteristics of PCa patients
| Variables | Values |
|---|---|
| Age (years) | |
| Mean ± SD | 66 ± 5 |
| Median (range) | 67 (57,70) |
| PSA at time of PET scan (ng/mL) | |
| Mean ± SD | 28.05 ± 26.91 |
| Median | 29.49 (7.33,53.11) |
| Pathologic stage (%) | |
| pT2a | 5 (9.6) |
| pT2b | 10 (19.2) |
| pT2c | 9 (17.4) |
| pT3a | 14 (26.9) |
| pT3b | 14 (26.9) |
| N0 | 30 (57.7) |
| N1 | 22 (42.3) |
| GS(%) | |
| 6 | 1 (1.9) |
| 7 | 8 (15.4) |
| 8 | 13 (25.0) |
| 9 | 20 (38.5) |
| 10 | 10 (19.2) |
| SVI (%) | |
| (−) | 33 (63.5) |
| (+) | 19 (36.5) |
| PNI (%) | |
| (−) | 40 (76.9) |
| (+) | 12 (23.1) |
| Surgical margins (%) | |
| (−) | 38 (73.1) |
| (+) | 14 (26.9) |
PSA prostate-specific antigen, GS Gleason Score, SVI seminal vesicle invasion, PNI perineural invasion